Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis
Description preview
Therapeutic agents that target the vascular endothelial growth factor (VEGF) have achieved remarkable
success in patients with the neovascular form of age-related macular degeneration (nAMD). An emerging
clinical problem, however, is that many of the nAMD patients develop subretinal fibrosis (SRF) after receiving
anti-VEGF therapy. SRF can cause…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click